Loading
Life sciences · Journal article
Edubiotik Jurnal Pendidikan Biologi Dan Terapan · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Hepatocellular carcinoma (HCC) continues to be a significant contributor to cancer-associated fatalities, highlighting the worldwide necessity for efficacious treatment approaches. This research assessed the impact of oxyhydrogen nanobubbles (HHOnbs) on β-catenin expression and CD8⁺ T-cell infiltration in a rat model of HCC caused by diethylnitrosamine (DEN) and carbon tetrachloride (CCl₄), while also contrasting their dose-dependent effects with Lenvatinib. Male Wistar rats were divided into six categories: negative control, positive control, HHOnbs given 12 or 24 times, and Lenvatinib provided 3 or 5 times. We evaluated β-catenin expression and the infiltration of CD8⁺ T-cells by immunohistochemical methods. HCC induction elevated β-catenin expression and augmented CD8⁺ T-cell infiltration. HHOnb treatment dose-dependently reduced β-catenin expression by 59.98% and 89.87% and increased CD8⁺ T-cell infiltration by 49.23% and 129.23% following 12 and 24 administrations, respectively. HHOnbs showed stronger β-catenin suppression, whereas Lenvatinib elicited greater CD8⁺ T-cell infiltration. These findings indicate that HHOnbs can suppress oncogenic signaling and enhance antitumor immune responses in experimental HCC. Future studies should assess their long-term efficacy and safety profiles and investigate combination therapies, as the present study did not evaluate these parameters.